Emergent Biosolutions Inc (NYSE: EBS) is 398.75% higher on its value in year-to-date trading and has touched a low of $1.42 and a high of $15.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EBS stock was last observed hovering at around $11.77 in the last trading session, with the day’s gains setting it 0.2%.
Currently trading at $11.97, the stock is 25.05% and 40.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing 1.70% at the moment leaves the stock 93.98% off its SMA200. EBS registered 456.74% gain for a year compared to 6-month gain of 123.32%. The firm has a 50-day simple moving average (SMA 50) of $8.4306 and a 200-day simple moving average (SMA200) of $6.12005.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 36.80% loss in the last 1 month and extending the period to 3 months gives it a 76.55%, and is 36.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.30% over the week and 7.78% over the month.
Emergent Biosolutions Inc (EBS) has around 1600 employees, a market worth around $693.99M and $1.13B in sales. Fwd P/E is 6.86. Profit margin for the company is -18.55%. Distance from 52-week low is 742.96% and -20.73% from its 52-week high. The company has generated returns on investments over the last 12 months (-17.68%).
with sales reaching $297.5M over the same period.The EPS is expected to grow by 82.99% this year, but quarterly earnings will post 6.90% year-over-year. Quarterly sales are estimated to grow 10.00% in year-over-year returns.
Emergent Biosolutions Inc (EBS) Top Institutional Holders
175.0 institutions hold shares in Emergent Biosolutions Inc (EBS), with institutional investors hold 58.73% of the company’s shares. The shares outstanding are 52.20M, and float is at 52.06M with Short Float at 14.97%. Institutions hold 57.47% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.84 million shares valued at $26.18 million. The investor’s holdings represent 7.3551% of the EBS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.67 million shares valued at $25.0 million to account for 7.0234 of the shares outstanding. The other top investors are CHARLES SCHWAB INVESTMENT MANAGEMENT INC which holds 3.17 million shares representing 6.0656% and valued at over $21.59 million, while MORGAN STANLEY holds 2.3796 of the shares totaling 1.24 million with a market value of $8.47 million.
Emergent Biosolutions Inc (EBS) Insider Activity
The most recent transaction is an insider sale by Zoon Kathryn C, the company’s Director. SEC filings show that Zoon Kathryn C sold 10,000 shares of the company’s common stock on Jun 04 ’24 at a price of $6.11 per share for a total of $61100.0. Following the sale, the insider now owns 54482.0 shares.
Emergent Biosolutions Inc disclosed in a document filed with the SEC on May 29 ’24 that Zoon Kathryn C (Director) sold a total of 1,830 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $4.61 per share for $8436.0. Following the transaction, the insider now directly holds 64482.0 shares of the EBS stock.
Still, SEC filings show that on May 21 ’24, Zoon Kathryn C (Director) disposed off 1,089 shares at an average price of $5.78 for $6294.0. The insider now directly holds 48,882 shares of Emergent Biosolutions Inc (EBS).
